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Background
Rosiglitazone is a thiazolidinedione derivative oral hypo-
glycemic agent active in both diabetic animal models and
type 2 diabetic patients. Rosiglitazone is a high affinity
ligand for the peroxisome proliferator-activated receptor
gamma, which is responsible for the insulin-sensitizing
action of the compound. Recent large clinical trials found
an association between the antidiabetic drug rosiglitazone
therapy and increased risk of cardiovascular adverse
events.
Methods
The aim of this report is to elucidate the cardiac elec-
trophysiological properties of rosiglitazone on control
and diabetic murine ventricular papillary muscles using
conventional microelectrode technique.
Results
In control histidine-decarboxylase knock-out mice
(HDC-KO) as well as in their wild-types (WT) rosiglita-
zone (1–30 μM) shortened AP duration at the 90% level
of repolarization (APD90) and increased the AP ampli-
tude (APA) in a concentration-dependent manner.
Moreover, rosiglitazone reduced the maximum velocity
of depolarization (Vmax). In diabetic animals we detected
very similar effects.
Conclusions
The action potential changes caused by rosiglitazone
probably can be explained by ion channel effects. The
observed alterations may carry a serious proarrhythmic
risk in case of overdose intoxication with rosiglitazone,
especially in patients having multiple cardiovascular risk
factors, like elderly diabetic patients.
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